| 摘要 |
The invention relates to a pharmaceutical composition comprising a systemic non-steroidal anti-inflammatory drug together with the histamine H2-antagonist 1-methyl- 5-[[3-[3-(1-piperidinylmethyl)phenoxy] propyl]amino]-1H- 1,2,4-triazole-3-methanol or a physiologically acceptable salt thereof. The histamine H2-antagonist reduces gastric mucosal lesions caused by the anti-inflammatory drug. |
